Omecamtiv Mecarbil not checked
Cytokinetics · AMG 423 · CK-1827452
FollowEvery change as it happens, and a Monday email
Trials
1 active
12 in total · 1 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Main trialPhase 3
- “The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in patients with heart failure and severely reduced ejection fraction.”In the company’s words, NCT06736574 on ClinicalTrials.gov
- Other names
- AMG 423 · CK-1827452
Other drugs for Heart Failure
- Balcinrenone/ dapagliflozinAstraZeneca · Phase 3
- DapagliflozinAstraZeneca · Phase 3
- HiCM-188HELP Therapeutics Co., Ltd. · Phase 3
- InclisiranNovartis Pharmaceuticals · Phase 3
- EmpagliflozinBoehringer Ingelheim · Phase 3
- VicadrostatBoehringer Ingelheim · Phase 3
Coming up1
- Sep 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials12
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Sep 2027 | Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction | |
| Phase 3Completed | 14 Sep 2020 | Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction | |
| Phase 3Completed | 8 Nov 2021 | Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure | |
| Phase 3Withdrawn | 27 Nov 2026 | Omecamtiv Mecarbil Post-trial Access Study | |
| Phase 2Completed | Feb 2009 | A Study of CK-1827452 Infusion in Stable Heart Failure | |
| Phase 2Withdrawn | May 2011 | Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients | |
| Phase 2Completed | Apr 2013 | Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF) | |
| Phase 2Completed | 22 Jul 2015 | COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure | |
| Phase 2Completed | 6 Apr 2017 | Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction | |
| Phase 1Completed | Jan 2013 | Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency | |
| Phase 1Completed | 6 Jan 2016 | Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults | |
| Phase 1Completed | 4 Mar 2020 | Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026